NASDAQ:SWAV Shockwave Medical (SWAV) Stock Price, News & Analysis → Make This $3 Trade the Instant the Opening Bell Rings (From Monument Traders Alliance) (Ad) Free SWAV Stock Alerts $277.11 +3.11 (+1.14%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$273.11▼$277.7050-Day Range$203.00▼$277.1152-Week Range$157.00▼$315.95Volume567,528 shsAverage Volume514,680 shsMarket Capitalization$10.36 billionP/E Ratio71.60Dividend YieldN/APrice Target$259.38 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Shockwave Medical alerts: Email Address Shockwave Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside6.4% Downside$259.38 Price TargetShort InterestHealthy4.55% of Shares Sold ShortDividend StrengthN/ASustainability-0.55Upright™ Environmental ScoreNews Sentiment1.18Based on 6 Articles This WeekInsider TradingSelling Shares$27.51 M Sold Last QuarterProj. Earnings Growth25.77%From $4.89 to $6.15 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.60 out of 5 starsMedical Sector74th out of 947 stocksSurgical & Medical Instruments Industry11th out of 99 stocks 1.4 Analyst's Opinion Consensus RatingShockwave Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 6 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $259.38, Shockwave Medical has a forecasted downside of 6.4% from its current price of $277.11.Amount of Analyst CoverageShockwave Medical has only been the subject of 3 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted4.55% of the outstanding shares of Shockwave Medical have been sold short.Short Interest Ratio / Days to CoverShockwave Medical has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Shockwave Medical has recently decreased by 11.46%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldShockwave Medical does not currently pay a dividend.Dividend GrowthShockwave Medical does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreShockwave Medical has received a 72.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Diagnostic and treatment machines" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Shockwave Medical is -0.55. Previous Next 3.4 News and Social Media Coverage News SentimentShockwave Medical has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Shockwave Medical this week, compared to 6 articles on an average week.Search Interest19 people have searched for SWAV on MarketBeat in the last 30 days. This is an increase of 73% compared to the previous 30 days.MarketBeat Follows9 people have added Shockwave Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 125% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Shockwave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $27,506,379.00 in company stock.Percentage Held by InsidersOnly 3.40% of the stock of Shockwave Medical is held by insiders.Percentage Held by Institutions87.35% of the stock of Shockwave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Shockwave Medical are expected to grow by 25.77% in the coming year, from $4.89 to $6.15 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shockwave Medical is 71.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 133.01.Price to Earnings Ratio vs. SectorThe P/E ratio of Shockwave Medical is 71.60, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 188.85.Price to Earnings Growth RatioShockwave Medical has a PEG Ratio of 2.25. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioShockwave Medical has a P/B Ratio of 15.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm Press8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: Click to get the name of the cryptocurrency About Shockwave Medical Stock (NASDAQ:SWAV)Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.Read More SWAV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SWAV Stock News HeadlinesMarch 17, 2024 | insidertrades.comShockwave Medical, Inc. (NASDAQ:SWAV) Director Sells $507,300.00 in StockMarch 15, 2024 | finance.yahoo.comCan Shockwave Medical, Inc. (NASDAQ:SWAV) Maintain Its Strong Returns?March 18, 2024 | Behind the Markets (Ad)The only AI company you should be looking atThis is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.March 12, 2024 | finance.yahoo.comSWAV Apr 2024 135.000 putMarch 8, 2024 | finance.yahoo.comDirector Frank Watkins Sells 2,000 Shares of Shockwave Medical Inc (SWAV)March 8, 2024 | americanbankingnews.comShockwave Medical, Inc. (NASDAQ:SWAV) Receives Average Rating of "Moderate Buy" from BrokeragesFebruary 29, 2024 | seekingalpha.comWhy Shockwave Medical Stands Out In The Medical Device SectorFebruary 28, 2024 | seekingalpha.comShockwave Medical Q4 Earnings Recap: Plenty Of Reasons To Stay BullishMarch 18, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.February 28, 2024 | seekingalpha.comShockwave Medical: Opening Arteries, Delivering ReturnsFebruary 28, 2024 | finance.yahoo.comShockwave Medical Inc Insider Sells SharesFebruary 25, 2024 | finance.yahoo.comSWAV Jun 2024 190.000 putFebruary 24, 2024 | msn.comShockwave Medical (SWAV) Price Target Increased by 10.79% to 262.70February 23, 2024 | benzinga.comInsider Decision: Frederic H Moll Offloads $15.44M Worth Of ShockWave Medical StockFebruary 23, 2024 | finance.yahoo.comShockWave Medical Inc Director Frederic Moll Sells 60,000 SharesFebruary 21, 2024 | benzinga.comLaura Francis At ShockWave Medical Decides to Exercises Options Worth $252KFebruary 19, 2024 | ca.finance.yahoo.comSWAV Mar 2024 270.000 putFebruary 18, 2024 | ca.finance.yahoo.comSWAV Mar 2024 280.000 putFebruary 18, 2024 | finance.yahoo.comEarnings Beat: Shockwave Medical, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their ModelsFebruary 17, 2024 | ca.finance.yahoo.comSWAV Jul 2024 230.000 putFebruary 17, 2024 | investors.comGeneral Motors, Celsius Lead Five Non-AI Stocks Near Buy PointsFebruary 17, 2024 | finanznachrichten.deShockwave Medical, Inc.: Shockwave Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 17, 2024 | ca.finance.yahoo.comSWAV Jan 2025 165.000 putFebruary 17, 2024 | ca.finance.yahoo.comSWAV Mar 2024 180.000 putFebruary 16, 2024 | marketwatch.comShockwave Medical Shares Rise 13% After 4Q Profit, Revenue BeatFebruary 16, 2024 | markets.businessinsider.comStrong Buy Rating for Shockwave Medical on Stellar Performance and Strategic PositioningFebruary 16, 2024 | markets.businessinsider.comBuy Rating for Shockwave Medical with Increased Price Target Amid Strong Performance and Growth ProspectsSee More Headlines Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/15/2024Today3/18/2024Next Earnings (Estimated)5/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:SWAV CUSIPN/A CIK1642545 Webwww.shockwavemedical.com Phone(877) 775-4846FaxN/AEmployees1,468Year FoundedN/APrice Target and Rating Average Stock Price Target$259.38 High Stock Price Target$310.00 Low Stock Price Target$210.00 Potential Upside/Downside-6.4%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)$3.87 Trailing P/E Ratio71.60 Forward P/E Ratio56.67 P/E Growth2.25Net Income$147.28 million Net Margins20.17% Pretax Margin23.87% Return on Equity23.97% Return on Assets12.78% Debt Debt-to-Equity Ratio1.09 Current Ratio11.76 Quick Ratio10.73 Sales & Book Value Annual Sales$730.23 million Price / Sales14.19 Cash Flow$4.49 per share Price / Cash Flow61.73 Book Value$18.12 per share Price / Book15.29Miscellaneous Outstanding Shares37,400,000Free Float36,126,000Market Cap$10.36 billion OptionableOptionable Beta0.90 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Douglas E. Godshall M.B.A. (Age 59)President, CEO & Director Comp: $1.57MMr. Isaac Zacharias (Age 49)Chief Commercial Officer Comp: $908.02kMr. Daniel Hawkins (Age 57)Founder and Senior Advisor Mr. John M. Adams (Age 77)Co-Founder and Technical Advisor Ms. Renee M. Gaeta (Age 42)Chief Financial Officer Mr. Luis MoralesSenior Vice President of Global OperationsMs. Trinh Phung (Age 46)Chief Accounting Officer, Principal Accounting Officer & VP of Finance Ms. Debbie KasterVice President of Investor RelationsMr. Hajime Tada J.D.General Counsel & SecretaryMr. Robert FletcherSenior Vice President of Marketing & Market AccessMore ExecutivesKey CompetitorsPenumbraNYSE:PENTeleflexNYSE:TFXStevanato GroupNYSE:STVNGlobus MedicalNYSE:GMEDInsuletNASDAQ:PODDView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 33,539 shares on 3/11/2024Ownership: 9.716%Trinh PhungSold 21 sharesTotal: $5,315.94 ($253.14/share)Frank T WatkinsSold 2,000 sharesTotal: $507,300.00 ($253.65/share)Wellington Management Group LLPBought 664,648 shares on 3/5/2024Ownership: 6.605%Fisher Asset Management LLCBought 417 shares on 3/5/2024Ownership: 0.203%View All Insider TransactionsView All Institutional Transactions SWAV Stock Analysis - Frequently Asked Questions Should I buy or sell Shockwave Medical stock right now? 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SWAV shares. View SWAV analyst ratings or view top-rated stocks. What is Shockwave Medical's stock price target for 2024? 8 Wall Street research analysts have issued 1 year target prices for Shockwave Medical's stock. Their SWAV share price targets range from $210.00 to $310.00. On average, they anticipate the company's stock price to reach $259.38 in the next year. This suggests that the stock has a possible downside of 6.4%. View analysts price targets for SWAV or view top-rated stocks among Wall Street analysts. How have SWAV shares performed in 2024? Shockwave Medical's stock was trading at $190.56 at the beginning of the year. Since then, SWAV shares have increased by 45.4% and is now trading at $277.11. View the best growth stocks for 2024 here. When is Shockwave Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our SWAV earnings forecast. How were Shockwave Medical's earnings last quarter? Shockwave Medical, Inc. (NASDAQ:SWAV) released its earnings results on Thursday, February, 15th. The company reported $1.16 earnings per share for the quarter, topping the consensus estimate of $0.92 by $0.24. The company had revenue of $202.98 million for the quarter, compared to analyst estimates of $199.43 million. Shockwave Medical had a trailing twelve-month return on equity of 23.97% and a net margin of 20.17%. The firm's revenue for the quarter was up 41.0% on a year-over-year basis. During the same period in the prior year, the firm earned $3.71 EPS. What ETFs hold Shockwave Medical's stock? ETFs with the largest weight of Shockwave Medical (NASDAQ:SWAV) stock in their portfolio include Neuberger Berman Disrupters ETF (NBDS), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), First Trust Indxx Medical Devices ETF (MDEV), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Alger Mid Cap 40 ETF (FRTY), WisdomTree U.S. Growth & Momentum Fund (WGRO) and First Trust Health Care AlphaDEX Fund (FXH). What guidance has Shockwave Medical issued on next quarter's earnings? Shockwave Medical issued an update on its FY 2024 earnings guidance on Friday, February, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $910.0 million-$930.0 million, compared to the consensus revenue estimate of $918.9 million. What is Doug Godshall's approval rating as Shockwave Medical's CEO? 8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees. What other stocks do shareholders of Shockwave Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA). When did Shockwave Medical IPO? (SWAV) raised $75 million in an initial public offering on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers. Who are Shockwave Medical's major shareholders? Shockwave Medical's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.85%), Vanguard Group Inc. (9.72%), Wellington Management Group LLP (6.61%), Artisan Partners Limited Partnership (4.05%), Price T Rowe Associates Inc. MD (2.13%) and Price T Rowe Associates Inc. MD (2.13%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Frederic H Moll, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sara Toyloy and Trinh Phung. View institutional ownership trends. How do I buy shares of Shockwave Medical? Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SWAV) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetryThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shockwave Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.